Income Statement

KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Apr 30, 2025 2025 FY
Revenue	59.82
Cost of Revenue	35.61
Gross Profit	24.21
Operating Expenses	130.59
Research & Development	15.65
Selling, General & Administrative	114.94
Other Operating Expenses	-
Operating Income	-106.38
Non-Operating Income	7.30
Interest Income	3.20
Interest Expense	-
Other Non-Op Income / Expense	-2.77
Income Before Tax	-113.68
Income Tax Expense	0.14
Non-Controlling Interest	-
Net Income	-113.81

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted